This may be because ICIs immunize atherosclerotic T cells through the regulation of T-cell activation, leading to increased interferon-gamma and tumor necrosis factor (TNF)-alpha levels, thereby increasing the risk of coronary thrombosis (68). The gene discussed is TNF; the disease is deep vein thrombosis.